Mr Anand P Panwalker, MD | |
C78 80 Omega Drive, Newark, DE 19713 | |
(302) 368-2883 | |
(302) 368-2892 |
Full Name | Mr Anand P Panwalker |
---|---|
Gender | Male |
Speciality | Internal Medicine - Infectious Disease |
Location | C78 80 Omega Drive, Newark, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609937267 | NPI | - | NPPES |
1000022199 | Medicaid | DE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | C10002557 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Anand P Panwalker, MD C78 80 Omega Drive, Newark, DE 19713 Ph: (302) 368-2883 | Mr Anand P Panwalker, MD C78 80 Omega Drive, Newark, DE 19713 Ph: (302) 368-2883 |
News Archive
A selection of health policy news from Oregon, Texas, Maryland, California, Georgia and Wisconsin.
The Advertising Standards Authority (ASA) has ruled there is no case to answer after a complaint by the Salt Manufacturers Association (SMA) regarding the Food Standards Agency's (FSA) recent salt awareness campaign.
Traumatic brain injury (TBI) is a serious public health problem in the United States. Recent data show that approximately 1.7 million people sustain a traumatic brain injury annually. While the majority of TBIs are concussions or other mild forms, traumatic brain injuries contribute to a substantial number of deaths and cases of permanent disability.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the peer-reviewed publication of the primary outcome results of the Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy (MINDACT) clinical trial in the prestigious New England Journal of Medicine (NEJM). (i, iii, iv) The publication demonstrates that 46% of breast cancer patients considered for chemotherapy, whose tumors are classified MammaPrint Low Risk, have excellent survival without chemotherapy, and can thus be candidates to avoid this toxic therapy.
› Verified 8 days ago
Shruti Puri, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd Ste 5a43, Newark, DE 19718 Phone: 302-623-0188 Fax: 302-733-5640 | |
Zaid A Ammari, M.D. M.P.H. Infectious Disease Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 Fax: 347-851-8707 | |
Dr. Suresh Trivedi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Continental Dr, Suite 406, Newark, DE 19713 Phone: 302-368-2630 Fax: 302-368-1271 | |
Dr. Bradley Bley, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1096 Old Churchmans Rd, Newark, DE 19713 Phone: 302-655-9494 Fax: 302-351-4898 | |
Dr. Avinash Chandra, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 86 Omega Dr, Omega Professional Center, Building B-86, Newark, DE 19713 Phone: 302-366-1929 Fax: 302-366-1006 | |
Dr. Lucinda Li, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd Ste 5a43, Newark, DE 19718 Phone: 302-623-0188 | |
Dr. James Robinson Mcninch Iv, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1148 |